Angiocidin Inhibitory Peptides Decrease Tumor Burden in a Murine Colon Cancer Model

Journal of Surgical Research

Volumn 142, Issue 2, 2007, Pages 320-326

  Liebig, Catherine ^a   Agarwal, Neeti ^a   Ayala, Gustavo E ^a   Verstovsek, Gordana ^a   Tuszynski, George P ^b   Albo, Daniel ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

angiocidin; angiocidin inhibitory peptide; colon cancer; CSVTCG; nude mouse model; peptide therapy; tissue array; tumor burden; xenograft model

Indexed keywords

ANGIOCIDIN; ANTINEOPLASTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON CANCER; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIVER METASTASIS; LYMPH NODE METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; TUMOR GROWTH; TUMOR VOLUME; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; CARRIER PROTEINS; CELL LINE, TUMOR; COLON; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, NUDE; PEPTIDE FRAGMENTS; SPLEEN; THROMBOSPONDIN 1; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 34548674008     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.02.036     Document Type: Article

References (19)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106
2. National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program Fast Stats: Colon and Rectum Cancer.
3. Yang X., Rothman V.L., L'Heureux D.Z., et al. Reduction of angiocidin expression in human umbilical vein endothelial cells via siRNA silencing inhibits angiogenesis. Exp Mol Pathol 81 (2006) 108
4. Zhou J., Rothman V.L., Sargiannidou I., et al. Cloning and characterization of angiocidin, a tumor cell binding protein for thrombospondin-1. J Cell Biochem 92 (2004) 125
5. Sabherwal Y., Rothman V.L., Dimitrov S., et al. Integrin α2β1 mediates the antiangiogenic and antitumor activities of angiocidin, a novel tumor-associated protein. Exp Cell Res 312 (2006) 2443
6. Sabherwal Y., Rothman V.L., Poon R.T., et al. Clinical significance of serum angiocidin levels in hepatocellular carcinoma. Cancer Lett (2006)
7. Roth J.J., Buckmire M.A., Rolandelli R.H., et al. Localization of thrombospondin-1 and its cysteine-serine-valine-threonine-cysteine-glycine receptor in colonic anastomotic healing tissue. Histol Histopathol 13 (1998) 967
8. Roth J.J., Sung J.J., Granick M.S., et al. Thrombospondin 1 and its specific cysteine-serine-valine-threonine-cysteine-glycine receptor in fetal wounds. Ann Plast Surg 42 (1999) 553
9. Poon R.T., Chung K.K., Cheung S.T., et al. Clinical significance of thrombospondin 1 expression in hepatocellular carcinoma. Clin Cancer Res 10 (2004) 4150
10. Albo D., Shinohara T., and Tuszynski G.P. Up-regulation of matrix metalloproteinase 9 by thrombospondin 1 in gastric cancer. J Surg Res 108 (2002) 51
11. Tuszynski G.P., Rothman V.L., Papale M., et al. Identification and characterization of a tumor cell receptor for CSVTCG, a thrombospondin adhesive domain. J Cell Biol 120 (1993) 513
12. Tuszynski G.P., Rothman V.L., Deutch A.H., et al. Biological activities of peptides and peptide analogs derived from common sequences present in thrombospondin, properdin, and malarial proteins. J Cell Biol 116 (1992) 209
13. Tuszynski G.P., and Nicosia R.F. Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma. Lab Invest 70 (1994) 228
14. Arnoletti J.P., Albo D., Jhala N., et al. Computer-assisted image analysis of tumor sections for a new thrombospondin receptor. Am J Surg 168 (1994) 433
15. Wakiyama T., Shinohara T., Shirakusa T., et al. The localization of thrombospondin-1 (TSP-1), cysteine-serine-valine-threonine-cysteine-glycine (CSVTCG) TSP receptor, and matrix metalloproteinase-9 (MMP-9) in colorectal cancer. Histol Histopathol 16 (2001) 345
16. Sabherwal Y, Rothman V, Albo D, et al. Angiocidin, an endogenous inhibitor of angiogenesis, is increased in the sera of cancer patients. Proceedings of the American Association for Cancer Research 2004;45:Abstract 4950.
17. Sargiannidou I., Qiu C., and Tuszynski G.P. Mechanisms of thrombospondin-1-mediated metastasis and angiogenesis. Semin Thromb Hemost 30 (2004) 127
18. Nicosia R.F., and Tuszynski G.P. Matrix-bound thrombospondin promotes angiogenesis in vitro. J Cell Biol 124 (1994) 183
19. Parulekar W.R., and Eisenhauer E.A. Phase I trial design for solid tumor studies of targeted, noncytotoxic agents: Theory and practice. J Natl Cancer Inst 96 (2004) 990